CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Dunwoody, Georgia, United States and 123 other locations
locally advanced or metastatic disease.In addition, HER3-DXd will be evaluated in participants with locally advanced or metastatic NSCLC whose tumors...
Phase 1
Atlanta, Georgia, United States and 36 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Gainesville, Georgia, United States and 97 other locations
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...
Phase 2
Atlanta, Georgia, United States and 80 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Atlanta, Georgia, United States and 256 other locations
is Phase 1/2, multicenter, clinical study to evaluate the safety, efficacy, PK, and immunogenicity of IDE849 in subjects with DLL3-expressing tumors...
Phase 1, Phase 2
Atlanta, Georgia, United States and 38 other locations
or cisplatin, for the first-line treatment of adult participants with KRAS G12C-mutated, advanced or metastatic non squamous non-small cell lung...
Phase 3
Atlanta, Georgia, United States and 150 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Marietta, Georgia, United States and 182 other locations
This phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung...
Phase 1
Atlanta, Georgia, United States and 2 other locations
This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...
Phase 2
Atlanta, Georgia, United States and 56 other locations
Clinical trials
Research sites
Resources
Legal